摘要
目的评价小肝癌经导管内亚肝段动脉栓塞化疗 (S TACE)后的疗效及价值。方法回顾性分析 12例小肝癌病人 18个病灶 34次S TACE治疗后情况 ,并行CT随访 (最短 6个月 ,最长 3年 )。结果治疗后 2周 ,83 4%的患者AFP水平有不同程度下降。CT显示S TACE治疗 1～ 2次后 ,2 7 8%的患者病灶明显缩小至原病灶直径的一半以下。患者 1年、2年、3年生存率分别为 83 4%、6 6 8%、5 8 6 %。结论S TACE可作为小肝癌的主要治疗手段。
Objective To evaluate the therapeutical effect of subsegmental transcatheter arterial chermoembolization (S TACE) on small hepatocellular carcinoma (SHCC). Methods 12 cases with 18 lesions were treated with 34 times S TACE. All patients were followed up (from half a year to three years). Results Two weeks after S-TACE, serum alpha fetoprotein level decreased in 83.4%. The CT indicated that the tumor size reduced more than 50% in 27.8% lesions. The patients survival rates were 83.4%, 66.8%, 58.6% in 1,2,3 year respectively. Conclusion S TACE could serve as an important therapeutic method for SHCC.
出处
《贵州医药》
CAS
2001年第4期302-304,F002,共4页
Guizhou Medical Journal
关键词
小肝癌
亚肝段
肝动脉栓塞化疗
疗效
SHCC Embolization,therapeutic Computer Tomography Prognosis
